Abstract
Opportunistic diseases cause substantial morbidity and mortality to human immunodeficiency virus (HIV)-infected patients. Highly active antiretroviral therapy (HAART) leading to immune reconstitution is the most effective treatment of preventing opportunistic diseases. This retrospective study established an epidemiologic profile of opportunistic diseases 10 years after the introduction of HAART. The HIV antiretroviral therapy-naive patients matching inclusion criteria were included. The primary outcome was the prevalence of opportunistic diseases. From January 1, 2002 to September 30, 2010, 654 opportunistic diseases were identified in 458 patients. Pulmonary tuberculosis, herpes zoster, cerebral toxoplasmosis, oral candidiasis, and severe pneumonia accounted for 22.05%, 15.94%, 14.19%, 14.19%, and 9.39%, respectively. Cryptococcal meningitis and pneumocystosis accounted for 0.44% and 0.21%, respectively. The prevalence of opportunistic diseases in Gabon remains high. New guidelines emphasize the importance of initiating antiretroviral therapy early to reconstitute the immune system, and reduce disease risk, and treat the primary opportunistic infection of pulmonary tuberculosis. Copyright © 2014 by The American Society of Tropical Medicine and Hygiene.
Cite
CITATION STYLE
Okome-Nkoumou, M., Guiyedi, V., Ondounda, M., Efire, N., Clevenbergh, P., Dibo, M., & Dzeing-Ella, A. (2014). Opportunistic diseases in HIV-infected patients in gabon following the administration of highly active antiretroviral therapy: A retrospective study. American Journal of Tropical Medicine and Hygiene, 90(2), 211–215. https://doi.org/10.4269/ajtmh.12-0780
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.